SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-055689
Filing Date
2024-05-08
Accepted
2024-05-08 16:15:20
Documents
12
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20240508.htm   iXBRL 8-K 46894
2 EX-99.1 crsp-ex99_1.htm EX-99.1 130165
  Complete submission text file 0000950170-24-055689.txt   304353

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crsp-20240508.xsd EX-101.SCH 25983
15 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20240508_htm.xml XML 4500
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 24926262
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)